Login Register Cart 0
Generic placeholder image

Current Vascular Pharmacology

Editor-in-Chief

ISSN (Print): 1570-1611
ISSN (Online): 1875-6212

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Letter to the Editor

Epigenetic Changes as a Possible Mechanism Leading to Increased Fetal Cardiovascular Disease Risk in Pregnancies with Gestational Diabetes Mellitus and/or Maternal Hypercholesterolemia

Author(s): Cristian Espinoza, Barbara Fuenzalida and Andrea Leiva*

Volume 20, Issue 4, 2022

Published on: 14 March, 2022

Page: [381 - 381] Pages: 1

DOI: 10.2174/1570161120666220314090700

« Previous
[1]
Espinoza C, Fuenzalida B, Leiva A. Increased Fetal Cardiovascular Disease Risk: Potential Synergy Between Gestational Diabetes Mellitus and Maternal Hypercholesterolemia. Curr Vasc Pharmacol 2021; 19(6): 601-23.
[2]
Briana D, Malamitsi-Puchner A. Effect of gestational diabetes mellitus and hypercholesterolemia on fetal cardiovascular disease risk: The role of epigenetics. Curr Vasc Pharmacol 2021.
[3]
Kerr B, Leiva A, Farías M, et al. Placenta. Foetoplacental epigenetic changes associated with maternal metabolic dysfunction. Placenta 2018; 69: 146-52.
[4]
Contreras-Duarte S, Cantin C, Farias M, Leiva A. High total cholesterol and triglycerides levels increase arginases metabolism, impairing nitric oxide signaling and worsening fetoplacental endothelial dysfunction in gestational diabetes mellitus pregnancies. Biochim Biophys Acta Mol Basis Dis 2021; 1867(12): 166216.
[5]
Contreras-Duarte S, Carvajal L, Fuenzalida B, Cantin C, Sobrevia L, Leiva A. Maternal dyslipidaemia in pregnancy with gestational diabetes mellitus: Possible impact on foetoplacental vascular function and lipoproteins in the neonatal circulation. Curr Vasc Pharmacol 2019; 17(1): 52-71.

Rights & Permissions Print Cite
Article Metrics
3
© 2024 Bentham Science Publishers | Privacy Policy